ACUITY MEDICAL MACULAR DEGENERATION DEVICE SHOWS POSITIVE RESULTS IN FDA TRIAL

Acuity Medical has successfully completed a proof of concept FDA-compliant trial of its TheraMac device for the treatment of dry age-related macular degeneration (AMD). AMD is the leading cause of legal blindness effecting more than 50 million people worldwide. The trial showed that in two weeks 26 percent of the eyes treated had improved vision by 10 letters or more, the equivalent of two lines on the eye chart. There were zero serious adverse events.
Yahoo News